IDPC lays out the main challenges and opportunities offered by the upcoming 2024 mid-term review, underscoring that the objectives set out in 2019 have not been met and that a new approach is urgently needed.
AIDS Action Europe present guidance on adapting harm reduction principles to individuals engaged in chemsex, taking into account the intersectional identities of those involved.
The International Coalition on Drug Policy Reform and Environmental Justice shines a light on how global drug prohibition fuels organised crime, corruption and environmental devastation, and calls for closer collaboration between environmental and drug policy movements.
Joshi et al. found that decriminalisation was not associated with increased overdose rates one year after implementation, despite recent US media claims to the contrary.
Rioux et al. explore the ways in which virtual overdose monitoring services and overdose detection technologies can help to expand the reach of 'traditional' harm reduction interventions whilst highlighting concerns —including related to privacy and surveillance.
Levenson et al. note how the overdose crisis in the United States is inextricably linked to wider systems of criminalisation and incarceration, calling for the abolition of policing and prisons in order to uproot structural causes of harm.
Drug Policy Alliance underscore how chronic underinvestment in public services and the criminalisation of social issues have fuelled several concurrent crises, calling for increased investment in jobs, education, housing, and health care.
EuroNPUD advocate for peer-led harm reduction delivered by, with and for people who use drugs and provide technical resources that support the delivery of peer-led harm reduction by drug user organisations and peer work projects.
Van Amsterdam et al. present the first set of empirical findings relating to generic drug legislation in the UK and Germany, revealing it to be largely ineffective in counteracting NPS use and causing increased public health problems.
Paradise et al. underscore the importance of incorporating the voices of people experiencing homelessness into the development of housing and substance use treatment programs, in order to reduce the risk of overdose and protect those most vulnerable to the intersecting housing and opioid overdose crises.